GlassScriptPhysician profile
Timothy Luke Cramer
NPI 1275947335
$3,480.17
in general payments reported to CMS, 2019-2025
11 companies · $776 in 2025
The $776 reported for 2025 was more than what a typical Interventional Pain Medicine provider received nationally (typical 2025 total: $676).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $400 · 2020: $56.23 · 2021: $670 · 2022: $729 · 2023: $470 · 2024: $379 · 2025: $776.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,595 · Education: $29.08.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,595.05 |
| Education | $29.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,902.57 | 2021-2025 | Intellis Adaptivestim, Inceptiv, Accurian |
| Collegium Pharmaceutical, INC. | $327.30 | 2019-2024 | Belbuca, Xtampza |
| Boston Scientific Corporation | $293.28 | 2024-2025 | Intracept |
| Medtronic USA, INC. | $249.71 | 2019 | |
| Grt US Holding, INC. | $244.51 | 2021-2022 | |
| Curonix LLC | $97.95 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Forte Bio-Pharma LLC | $96.85 | 2022-2025 | Prolate, Nalocet, Tanlor |
| Biodelivery Sciences International, INC. | $87.48 | 2020-2021 | |
| Stimwave Technologies Incorporated | $68.49 | 2022 | |
| Pfizer INC. | $61.88 | 2019 | |
| Scilex Pharmaceuticals INC. | $50.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Cramer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.